Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Spata2L | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPATA2L mRNA] | CTD | PMID:31150632 | Spata2L | Rat | 1,2-dichloroethane | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SPATA2L mRNA | CTD | PMID:28189721|PMID:28960355 | Spata2L | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SPATA2L mRNA | CTD | PMID:30723492 | Spata2L | Rat | 17beta-estradiol | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Estradiol results in decreased expression of SPATA2L mRNA | CTD | PMID:39298647 | Spata2L | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SPATA2L mRNA | CTD | PMID:27291303 | Spata2L | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SPATA2L mRNA | CTD | PMID:21632981 | Spata2L | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPATA2L mRNA | CTD | PMID:32109520 | Spata2L | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPATA2L mRNA | CTD | PMID:19770486|PMID:26290441 | Spata2L | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Spata2l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPATA2L mRNA | CTD | PMID:24680724|PMID:26377647 | Spata2L | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SPATA2L mRNA | CTD | PMID:39298647 | Spata2L | Rat | aflatoxin B1 | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of SPATA2L mRNA | CTD | PMID:19770486 | Spata2L | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPATA2L mRNA | CTD | PMID:35163327 | Spata2L | Rat | amiodarone | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Amiodarone results in increased expression of SPATA2L mRNA | CTD | PMID:19774075 | Spata2L | Rat | benzo[a]pyrene | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SPATA2L mRNA | CTD | PMID:19770486 | Spata2L | Rat | benzo[a]pyrene | increases methylation | ISO | SPATA2L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SPATA2L promoter | CTD | PMID:27901495 | Spata2L | Rat | benzo[b]fluoranthene | increases expression | ISO | Spata2l (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of SPATA2L mRNA | CTD | PMID:26377693 | Spata2L | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SPATA2L mRNA | CTD | PMID:25181051 | Spata2L | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SPATA2L mRNA | CTD | PMID:32145629 | Spata2L | Rat | bisphenol F | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SPATA2L mRNA | CTD | PMID:38685157 | Spata2L | Rat | cadmium atom | multiple interactions | ISO | Spata2l (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPATA2L more ... | CTD | PMID:37236586 | Spata2L | Rat | cadmium dichloride | multiple interactions | ISO | Spata2l (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPATA2L more ... | CTD | PMID:37236586 | Spata2L | Rat | carbon nanotube | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of SPATA2L mRNA | CTD | PMID:25620056 | Spata2L | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of SPATA2L mRNA | CTD | PMID:22023808 | Spata2L | Rat | cisplatin | decreases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SPATA2L mRNA | CTD | PMID:27392435 | Spata2L | Rat | clofibrate | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SPATA2L mRNA | CTD | PMID:23811191 | Spata2L | Rat | coumestrol | decreases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of SPATA2L mRNA | CTD | PMID:19167446 | Spata2L | Rat | cyclosporin A | increases expression | ISO | Spata2l (Mus musculus) | 6480464 | Cyclosporine results in increased expression of SPATA2L mRNA | CTD | PMID:25270620 | Spata2L | Rat | cyclosporin A | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SPATA2L mRNA | CTD | PMID:25562108 | Spata2L | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of SPATA2L mRNA | CTD | PMID:23640034 | Spata2L | Rat | diazinon | increases methylation | ISO | SPATA2L (Homo sapiens) | 6480464 | Diazinon results in increased methylation of SPATA2L gene | CTD | PMID:22964155 | Spata2L | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SPATA2L mRNA | CTD | PMID:29391264 | Spata2L | Rat | epoxiconazole | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SPATA2L mRNA | CTD | PMID:35436446 | Spata2L | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of SPATA2L mRNA | CTD | PMID:30307764 | Spata2L | Rat | folic acid | increases expression | ISO | Spata2l (Mus musculus) | 6480464 | Folic Acid results in increased expression of SPATA2L mRNA | CTD | PMID:25629700 | Spata2L | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of SPATA2L mRNA | CTD | PMID:26194646 | Spata2L | Rat | genistein | decreases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Genistein results in decreased expression of SPATA2L mRNA | CTD | PMID:16705744 | Spata2L | Rat | iron dichloride | decreases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of SPATA2L mRNA | CTD | PMID:35984750 | Spata2L | Rat | Licochalcone B | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | licochalcone B results in increased expression of SPATA2L mRNA | CTD | PMID:33647349 | Spata2L | Rat | okadaic acid | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of SPATA2L mRNA | CTD | PMID:38832940 | Spata2L | Rat | ozone | multiple interactions | ISO | SPATA2L (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SPATA2L mRNA | CTD | PMID:35430440 | Spata2L | Rat | paracetamol | affects expression | ISO | Spata2l (Mus musculus) | 6480464 | Acetaminophen affects the expression of SPATA2L mRNA | CTD | PMID:17562736 | Spata2L | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SPATA2L mRNA | CTD | PMID:33387578 | Spata2L | Rat | paracetamol | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SPATA2L mRNA | CTD | PMID:21420995|PMID:29067470 | Spata2L | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPATA2L mRNA | CTD | PMID:35163327 | Spata2L | Rat | phenobarbital | affects expression | ISO | Spata2l (Mus musculus) | 6480464 | Phenobarbital affects the expression of SPATA2L mRNA | CTD | PMID:23091169 | Spata2L | Rat | pirinixic acid | multiple interactions | ISO | Spata2l (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Spata2L | Rat | pirinixic acid | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of SPATA2L mRNA | CTD | PMID:23811191 | Spata2L | Rat | propiconazole | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | propiconazole results in decreased expression of SPATA2L mRNA | CTD | PMID:21278054 | Spata2L | Rat | quercetin | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Quercetin results in increased expression of SPATA2L mRNA | CTD | PMID:21632981 | Spata2L | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of SPATA2L mRNA | CTD | PMID:31150632 | Spata2L | Rat | tetrachloromethane | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of SPATA2L mRNA | CTD | PMID:31919559 | Spata2L | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPATA2L mRNA] | CTD | PMID:31150632 | Spata2L | Rat | tetraphene | increases expression | ISO | Spata2l (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of SPATA2L mRNA | CTD | PMID:26377693 | Spata2L | Rat | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of SPATA2L mRNA | CTD | PMID:34492290 | Spata2L | Rat | titanium dioxide | affects expression | ISO | Spata2l (Mus musculus) | 6480464 | titanium dioxide affects the expression of SPATA2L mRNA | CTD | PMID:35295148 | Spata2L | Rat | triphenyl phosphate | affects expression | ISO | SPATA2L (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SPATA2L mRNA | CTD | PMID:37042841 | Spata2L | Rat | Triptolide | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | triptolide results in decreased expression of SPATA2L mRNA | CTD | PMID:32835833 | Spata2L | Rat | troglitazone | decreases expression | ISO | Spata2l (Mus musculus) | 6480464 | troglitazone results in decreased expression of SPATA2L mRNA | CTD | PMID:28973697 | Spata2L | Rat | valproic acid | increases expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SPATA2L mRNA | CTD | PMID:23179753 | Spata2L | Rat | valproic acid | affects expression | ISO | SPATA2L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SPATA2L mRNA | CTD | PMID:25979313 | Spata2L | Rat | zinc atom | multiple interactions | ISO | SPATA2L (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPATA2L mRNA | CTD | PMID:18593933 | Spata2L | Rat | zinc(0) | multiple interactions | ISO | SPATA2L (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPATA2L mRNA | CTD | PMID:18593933 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















